GlassScriptPhysician profile
Joseph Dubose
NPI 1871667576
$2,409.00
in general payments reported to CMS, 2019-2025
14 companies · $656 in 2025
The $656 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $127 · 2021: $42.23 · 2022: $43.02 · 2023: $234 · 2024: $1,025 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,667 · Education: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,667.41 |
| Education | $247.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $695.33 | 2023-2025 | Endurant Iis, Hawkone, Heli-Fx Endoanchor System |
| W. L. Gore & Associates, INC. | $428.43 | 2024-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Stent Graft, Gore Viabahn Endoprosthesis With Heparin |
| Penumbra, INC. | $346.60 | 2023-2024 | Penumbra System, Indigo System |
| Medtronic Vascular, INC. | $308.46 | 2019-2020 | |
| Inari Medical, INC. | $190.59 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Baxter Healthcare | $100.00 | 2019 | |
| Lemaitre Vascular, INC. | $85.88 | 2025 | Artegraft Vascular Graft, Eze-Sit Valvulotome |
| Boston Scientific Corporation | $70.21 | 2025 | Wallstent Rp Endoprosthesis |
| Mimedx Group, INC. | $47.82 | 2025 | |
| Terumo Medical Corporation | $43.02 | 2022 | |
| Prytime Medical Devices, INC. | $42.23 | 2021 | |
| Reflow Medical INC | $35.09 | 2025 | |
| Dilon Technologies, INC. | $15.34 | 2025 | Hemoblast Bellows |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Dubose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.